XNAS: DSGN
Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...
Read More
9.94
-0.08
(-0.80%)
242.9K
XNAS Volume
XNAS 13 Mar, 2026 1:45 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Design Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..